Small Ruminant Lentiviruses: Genetic Variability, Tropism and Diagnosis
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Murine Models for Evaluating Antiretroviral Therapy1
[CANCER RESEARCH (SUPPL.) 50. 56l8s-5627s, September 1, I990| Murine Models for Evaluating Antiretroviral Therapy1 Ruth M. Ruprecht,2 Lisa D. Bernard, Ting-Chao Chou, Miguel A. Gama Sosa, Fatemeh Fazely, John Koch, Prem L. Sharma, and Steve Mullaney Division of Cancer Pharmacology. Dana-Farber Cancer Institute ¡R.M. R., L. D. B., M. A. G. S.. F. F.. J. K.. P. L. S., S. M.J; Departments of Medicine [R. M. K.J. Pathology ¡M.A. G. S.J, and Biological Chemistry and Molecular Pharmacology [F. F., J. K., P. L. S.J. Harvard Medical School, Boston, Massachusetts 02115, and Memorial Sloan-Kettering Cancer Center ¡T-C.C.], New York, New York 10021 Abstract Prior to using a given animal model system to test a candidate anti-AIDS agent, the following questions need to be addressed: The pandemic of the acquired immunodeficiency syndrome (AIDS), (a) Is the potential anti-AIDS drug an antiviral agent or an caused by the human immunodeficiency virus type 1 (IIIV-I ). requires immunomodulator that may be able to restore certain immune rapid development of effective therapy and prevention. Analysis of can didate anti-HIV-1 drugs in animals is problematic since no ideal animal functions? Thus, is a candidate anti-AIDS drug likely to be model for IIIV-I infection and disease exists. For many reasons, including active during the phase of asymptomatic viremia or only during small size, availability of inbred strains, immunological reagents, and overt disease? (¿>)Does a candidate antiviral agent inhibit a lymphokines, murine systems have been used for in vivo analysis of retroviral function shared by all retroviruses such as gag, pol, antiretroviral agents. -
Molecular Characterization of Human Papillomavirus Type 159 (HPV159)
viruses Article Molecular Characterization of Human Papillomavirus Type 159 (HPV159) Iva Markovi´c 1, Lea Hošnjak 2 , Katja Seme 2 and Mario Poljak 2,* 1 Division of Molecular Biology, Ruder¯ Boškovi´cInstitute, BijeniˇckaCesta 54, 10000 Zagreb, Croatia; [email protected] 2 Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Zaloška Cesta 4, 1105 Ljubljana, Slovenia; [email protected] (L.H.); [email protected] (K.S.) * Correspondence: [email protected]; Tel.: +386-1-543-7453 Abstract: Human papillomavirus type 159 (HPV159) was identified in an anal swab sample and preliminarily genetically characterized by our group in 2012. Here we present a detailed molecular in silico analysis that showed that the HPV159 viral genome is 7443 bp in length and divided into five early and two late genes, with conserved functional domains and motifs, and a non-coding long control region (LCR) with significant regulatory sequences that allow the virus to complete its life cycle and infect novel host cells. HPV159, clustering into the cutaneotropic Betapapillomavirus (Beta-PV) genus, is phylogenetically most similar to HPV9, forming an individual phylogenetic group in the viral species Beta-2. After testing a large representative collection of clinical samples with HPV159 type-specific RT-PCR, in addition to the anal canal from which the first HPV159 isolate was obtained, HPV159 was further detected in other muco-cutaneous (4/181, 2.2%), mucosal (22/764, 2.9%), and cutaneous (14/554, 2.5%) clinical samples, suggesting its extensive tissue tropism. However, because very low HPV159 viral loads were estimated in the majority of positive samples, Citation: Markovi´c,I.; Hošnjak, L.; it seemed that HPV159 mainly caused clinically insignificant infections of the skin and mucosa. -
A Proposal for a New Approach to a Preventive Vaccine Against Human Immunodeficiency Virus Type 1 (Simpler Retrovirus/More Complex Retrovirus/Co-Virus) HOWARD M
Proc. Natl. Acad. Sci. USA Vol. 90, pp. 4419-4420, May 1993 Medical Sciences A proposal for a new approach to a preventive vaccine against human immunodeficiency virus type 1 (simpler retrovirus/more complex retrovirus/co-virus) HOWARD M. TEMIN McArdle Laboratory, 1400 University Avenue, Madison, WI 53706 Contributed by Howard M. Temin, February 22, 1993 ABSTRACT Human immunodeficiency virus type 1 retroviruses infected our ancestors, as shown by the relic (HIV-1) is a more complex retrovirus, coding for several proviruses in human DNA (7-16). accessory proteins in addition to the structural proteins (Gag, More complex retroviruses were first isolated in horses Pol, and Env) that are found in all retroviruses. More complex (equine infectious anemia virus). Since then they have been retroviruses have not been isolated from birds, and simpler isolated from many other mammals, including at least five retroviruses have not been isolated from humans. However, the from humans (HIV-1, HIV-2, HTLV-I, HTLV-II, and proviruses of many endogenous simpler retroviruses are pres- HSRV). So far, more complex retroviruses have not been ent in the human genome. These observations suggest that isolated from vertebrate families other than mammals, and humans can mount a successful protective response against simpler retroviruses have not been isolated from humans or simpler retrovrwuses, whereas birds cannot. Thus, humans ungulates. However, more complex retroviruses have been might be able to mount a successful protective response to isolated from both humans and ungulates. infection with a simpler HIV-1. As a model, a simpler bovine I propose that this phylogenetic distribution is not an leukemia virus which is capable of replicating has been con- artifact of virus isolation techniques, but that it reflects the structed; a simpler HIV-1 could be constructed in a similar ability of humans and ungulates to respond to infection by fashion. -
Genetic Analysis of Bipartite Geminivirus Tissue Tropism
Virology 291, 311–323 (2001) doi:10.1006/viro.2001.1205, available online at http://www.idealibrary.com on View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Genetic Analysis of Bipartite Geminivirus Tissue Tropism Ying Qin1 and Ian T. D. Petty2 Department of Microbiology, North Carolina State University, Raleigh, North Carolina 27695-7615 Received July 31, 2001; returned to author for revision September 3, 2001; accepted September 18, 2001 The bipartite geminiviruses bean golden mosaic virus (BGMV), cabbage leaf curl virus (CabLCV), and tomato golden mosaic virus (TGMV) exhibit differential tissue tropism in Nicotiana benthamiana. In systemically infected leaves, BGMV remains largely confined to vascular-associated cells (phloem-limited), whereas CabLCV and TGMV can escape into the surrounding mesophyll. Previous work established that TGMV BRi, the noncoding region upstream from the BR1 open reading frame (ORF), is required for mesophyll invasion, but the virus must also contain the TGMV AL23 or BL1/BR1 ORFs. Here we show that, in a BGMV-based hybrid virus, CabLCV AL23 also directed efficient mesophyll invasion in conjunction with TGMV BRi, which suggests that host-adaptation of AL23 is important for the phenotype. Cis-acting elements required for mesophyll invasion were delineated by analyzing BGMV-based hybrid viruses in which various parts of BRi were exchanged with those of TGMV. Interestingly, mesophyll invasion efficiency of hybrid viruses was not correlated with the extent of viral DNA accumulation. In conjunction with TGMV AL23, a 52-bp region of TGMV BRi with sequence homology to DNA A was sufficient for mesophyll invasion. -
Viral Vectors 101 a Desktop Resource
Viral Vectors 101 A Desktop Resource Created and Compiled by Addgene www.addgene.org August 2018 (1st Edition) Viral Vectors 101: A Desktop Resource (1st Edition) Viral Vectors 101: A desktop resource This page intentionally left blank. 2 Chapter 1 - What Are Fluorescent Proteins? ViralViral Vectors Vector 101: A Desktop Resource (1st Edition) ViralTHE VectorsHISTORY 101: OFIntroduction FLUORESCENT to this desktop PROTEINS resource (CONT’D)By Tyler J. Ford | July 16, 2018 Dear Reader, If you’ve worked with mammalian cells, it’s likely that you’ve worked with viral vectors. Viral vectors are engineered forms of mammalian viruses that make use of natural viral gene delivery machineries and that are optimized for safety and delivery. These incredibly useful tools enable you to easily deliver genes to mammalian cells and to control gene expression in a variety of ways. Addgene has been distributing viral vectors since nearly its inception in 2004. Since then, our viral Cummulative ready-to-use virus distribution through June 2018. vector collection has grown to include retroviral vectors, lentiviral vectors, adenoviral vectors, and adeno-associated viral vectors. To further enable researchers, we started our viral service in 2017. Through this service, we distribute ready-to- use, quality-controlled AAV and lentivirus for direct use in experiments. As you can see in the chart to the left, this service is already very popular and its use has grown exponentially. With this Viral Vectors 101 eBook, we are proud to further expand our viral vector offerings. Within it, you’ll find nearly all of our viral vector educational content in a single downloadable resource. -
HIV-1 Non-Macrophage-Tropic R5 Envelope Glycoproteins Are Not More Tropic for Entry Into Primary CD4+ T-Cells Than Envelopes Highly Adapted for Macrophages
University of Massachusetts Medical School eScholarship@UMMS Open Access Articles Open Access Publications by UMMS Authors 2015-03-14 HIV-1 non-macrophage-tropic R5 envelope glycoproteins are not more tropic for entry into primary CD4+ T-cells than envelopes highly adapted for macrophages Thomas A. Musich University of Massachusetts Medical School Et al. Let us know how access to this document benefits ou.y Follow this and additional works at: https://escholarship.umassmed.edu/oapubs Part of the Immunology and Infectious Disease Commons, Virology Commons, Virus Diseases Commons, and the Viruses Commons Repository Citation Musich TA, O'Connell O, Gonzalez-Perez MP, Derdeyn CA, Peters PJ, Clapham PR. (2015). HIV-1 non- macrophage-tropic R5 envelope glycoproteins are not more tropic for entry into primary CD4+ T-cells than envelopes highly adapted for macrophages. Open Access Articles. https://doi.org/10.1186/ s12977-015-0141-0. Retrieved from https://escholarship.umassmed.edu/oapubs/2512 Creative Commons License This work is licensed under a Creative Commons Attribution 4.0 License. This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in Open Access Articles by an authorized administrator of eScholarship@UMMS. For more information, please contact [email protected]. Musich et al. Retrovirology (2015) 12:25 DOI 10.1186/s12977-015-0141-0 RESEARCH Open Access HIV-1 non-macrophage-tropic R5 envelope glycoproteins are not more tropic for entry into primary CD4+ T-cells than envelopes highly adapted for macrophages Thomas Musich1, Olivia O’Connell1, Maria Paz Gonzalez-Perez1, Cynthia A Derdeyn2,PaulJPeters1 and Paul R Clapham1,3* Abstract Background: Non-mac-tropic HIV-1 R5 viruses are predominantly transmitted and persist in immune tissue even in AIDS patients who carry highly mac-tropic variants in the brain. -
Epstein-Barr Virus Transcytosis Through Polarized Oral Epithelial Cells
Epstein-Barr Virus Transcytosis through Polarized Oral Epithelial Cells Sharof M. Tugizov,a,b Rossana Herrera,a Joel M. Palefskya,b Department of Medicinea and Department of Orofacial Sciences,b University of California San Francisco, San Francisco, California, USA Although Epstein-Barr virus (EBV) is an orally transmitted virus, viral transmission through the oropharyngeal mucosal epithe- lium is not well understood. In this study, we investigated how EBV traverses polarized human oral epithelial cells without caus- ing productive infection. We found that EBV may be transcytosed through oral epithelial cells bidirectionally, from both the apical to the basolateral membranes and the basolateral to the apical membranes. Apical to basolateral EBV transcytosis was substantially reduced by amiloride, an inhibitor of macropinocytosis. Electron microscopy showed that virions were surrounded by apical surface protrusions and that virus was present in subapical vesicles. Inactivation of signaling molecules critical for macropinocytosis, including phosphatidylinositol 3-kinases, myosin light-chain kinase, Ras-related C3 botulinum toxin sub- strate 1, p21-activated kinase 1, ADP-ribosylation factor 6, and cell division control protein 42 homolog, led to significant reduc- tion in EBV apical to basolateral transcytosis. In contrast, basolateral to apical EBV transcytosis was substantially reduced by nystatin, an inhibitor of caveolin-mediated virus entry. Caveolae were detected in the basolateral membranes of polarized hu- man oral epithelial cells, -
Epstein-Barr Virus Infection in Ex Vivo Tonsil Epithelial Cell Cultures of Asymptomatic Carriers Dirk M
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by DSpace at VU JOURNAL OF VIROLOGY, Nov. 2004, p. 12613–12624 Vol. 78, No. 22 0022-538X/04/$08.00ϩ0 DOI: 10.1128/JVI.78.22.12613–12624.2004 Copyright © 2004, American Society for Microbiology. All Rights Reserved. Epstein-Barr Virus Infection in Ex Vivo Tonsil Epithelial Cell Cultures of Asymptomatic Carriers Dirk M. Pegtel,1 Jaap Middeldorp,2 and David A. Thorley-Lawson1* Department of Pathology, Tufts University School of Medicine, Boston, Massachusetts,1 and Department of Pathology, Vrije Universiteit Medical Center, Amsterdam, The Netherlands2 Received 18 April 2004/Accepted 17 May 2004 Epstein-Barr virus (EBV) is found frequently in certain epithelial pathologies, such as nasopharyngeal carcinoma and oral hairy leukoplakia, indicating that the virus can infect epithelial cells in vivo. Recent studies of cell lines imply that epithelial cells may also play a role in persistent EBV infection in vivo. In this report, we show the establishment and characterization of an ex vivo culture model of tonsil epithelial cells, a likely site for EBV infection in vivo. Primary epithelial-cell cultures, generated from tonsil explants, contained a heterogeneous mixture of cells with an ongoing process of differentiation. Keratin expression profiles were consistent with the presence of cells from both surface and crypt epithelia. A small subset of cells could be latently infected by coculture with EBV-releasing cell lines, but not with cell-free virus. We also detected viral-DNA, -mRNA, and -protein expression in cultures from EBV-positive tonsil donors prior to in vitro infection. -
Tases from Ribonucleic Acid Tumor Viruses
JOURNAL OF VIROLOGY, Jan. 1972, p. 110-115 Vol. 9, No. I Copyright © 1972 American Society for Microbiology Printed in U.S.A. Immunological Relationships of Reverse Transcrip- tases from Ribonucleic Acid Tumor Viruses WADE P. PARKS, EDWARD M. SCOLNICK, JEFFREY ROSS, GEORGE J. TODARO, AND STUART A. AARONSON Viral Carcinogenesis Branch and Viral Leukemia and Lymphoma Branch, National Cancer Institute, Bethesda, Maryland 20014 Received for publication 12 October 1971 Antiserum to partially purified reverse transcriptase from the Schmidt-Ruppin strain of Rous sarcoma virus has been prepared and characterized. Antibody to the avian polymerase inhibited the reverse transcriptase activity of avian C-type viruses but had no effect on the polymerase activity from C-type viruses of other classes. The known mammalian C-type viral polymerases were significantly inhibited only by the antiserum to murine C-type viral polymerases; reverse transcriptases from four other mammalian viruses were immunologically distinct from both avian and mam- malian C-type viral polymerases. Partially purified murine leukemia viral DNA po- lymerase activity was comparably reduced by specific antibody regardless of the tem- plate used for enzyme detection. Antibody to the deoxyribonucleic acid (DNA) grown in a line of sheep testes cells and kindly pro- polymerase activities of murine C-type viruses vided by K. K. Takemoto and L. B. Stone (NIH, has been previously demonstrated in the sera of Bethesda, Md.). Mason-Pfizer monkey virus (MP- rats with murine leukemia virus (MuLV)-re- MV; reference 9) was grown in either monkey embryo cells or a human lymphoblastoid line (NC-37); some leasing tumors and in the sera of rabbits im- MP-MV preparations were provided by M. -
Animal Models for HIV AIDS: a Comparative Review
Comparative Medicine Vol 57, No 1 Copyright 2007 February 2007 by the American Association for Laboratory Animal Science Pages 33-43 Animal Models for HIV AIDS: A Comparative Review Debora S Stump and Sue VandeWoude* Human immunodeficiency virus (HIV), the causative agent for acquired immune deficiency syndrome, was described over 25 y ago. Since that time, much progress has been made in characterizing the pathogenesis, etiology, transmission, and disease syndromes resulting from this devastating pathogen. However, despite decades of study by many investigators, basic questions about HIV biology still remain, and an effective prophylactic vaccine has not been developed. This review provides an overview of the viruses related to HIV that have been used in experimental animal models to improve our knowledge of lentiviral disease. Viruses discussed are grouped as causing (1) nonlentiviral immunodeficiency-inducing diseases, (2) naturally occurring pathogenic infections, (3) experimentally induced lentiviral infections, and (4) nonpathogenic lentiviral infections. Each of these model types has provided unique contributions to our understanding of HIV disease; further, a comparative overview of these models both reinforces the unique attributes of each agent and provides a basis for describing elements of lentiviral disease that are similar across mammalian species. Abbreviations: AIDS, acquired immune deficiency syndrome; BIV, bovine immunodeficiency virus; CAEV, caprine arthritis-encephalitis virus; CRPRC, California Regional Primate Research -
Growth of Murine Sarcoma and Murine Xenotropic Leukemia Viruses in Japanese Quail: Induction of Tumors and Development of Continuous Tumor Cell Lines
[CANCER RESEARCH 42, 2523-2531, July 1982] 0008-5472/82/0042-OOOOS02.00 Growth of Murine Sarcoma and Murine Xenotropic Leukemia Viruses in Japanese Quail: Induction of Tumors and Development of Continuous Tumor Cell Lines W. G. Robey,1 W. J. Kuenzel, G. F. Vande Woude, and P. J. Fischinger Laboratory of Viral Carcinogenesis, National Cancer Institute, Frederick, Maryland 21701 [W. G. R., P. J. F.]; Department of Poultry Science, University of Maryland, College Park, Maryland 20724 [W. J. K.]; and Laboratory of Molecular Virology, National Cancer Institute, Bethesda, Maryland 20205 ¡G.F. V. W.] ABSTRACT and induces sarcomas in mice, rats, and hamsters (19, 32). Most MSV isolates do not have a functional reverse transcrip- The BALB/c murine endogenous xenotropic leukemia virus tase (31) or envelope glycoprotein (34, 36) or the genetic pseudotype of ml Moloney sarcoma virus [mlMSV(B-MuX)] information to specify those polypeptides (9, 39). In order to was used to productively transform diploid Japanese quail replicate, MSV isolates must obtain these functions from any embryo cells. The majority of newly hatched quail inoculated number of replicating helper viruses from various species (20, with ml MSV(B-MuX)-transformed quail embryo fibroblast cells 31 ). ml MSV (13) is a defective retrovirus containing nucleotide rapidly developed tumors which were predominantly locally sequences derived from M-MuLV (~3.8 kilobases) and normal invasive fibrosarcomas, but métastaseswere observed in two mouse cellular sequences, mos (~1.4 kilobases) (16, 39, 40). birds. In two tumor-bearing quail, lymphosarcomas were ob The mIMSV does express a portion of the leukemia virus served in conjunction with fibrosarcomas. -
Slow and Persistent Virus Infections of Neurones - a Compromise for Neuronal Survival
Slow and Persistent Virus Infections of Neurones - A Compromise for Neuronal Survival U.G. LIEBERT Introduction 35 2 Virus-Cell Interactions in the CNS. 36 2.1 Acute Infections . 37 2.2 Persistent Infections of the Nervous System. 38 Impact of Viral Infection on Specific Cell Functions .. 42 4 Immune-Mediated Antiviral Mechanisms .. 44 4.1 The Cell-Mediated Immune Response .. 48 4.2 Virus-Induced Cell-Mediated Autoimmune Reactions Against Brain Antigens 51 Consequences of Viral Persistence in Neurones .. 52 References . 53 1 Introduction Infections of the central nervous system (CNS) with intracellular pathogens are different in many respects from infections in other parts of the body due to both the anatomical and functional properties of the brain and the biological basis of im mune surveillance in the CNS. Damage to brain cells might have severe conse quences for the entire body and, in many instances, would conceivably interfere with vital functions. The CNS is particularly vulnerable to pathological stimuli since it consists of highly differentiated cell populations with complex functionally integrated cell-to-cell connections and specialised cytoplasmic membranes. Fur thermore, CNS tissue is unique in its high metabolic rate and relative lack of capacity to regenerate. While persistent infection by a non-cytopathogenic virus in cells of an organ with a low-energy requirement and a high rate of regeneration may be tolerated, in CNS tissue such infections may interfere with normal function, especially when neurones are affected (JOHNSON 1982). From this point of view, the paucity of lymphatic drainage and the lack of constitutive expression of immune regulatory molecules, e.g.